cd, schmahmann jd, cerebellar ataxia type 2 : a two - years follow - up tms study. clin edgerton j, et al. real - life ankle submovements and computer neurophysiol. 2018 ; 129 : 895 – 900. mouse use reflect patient - reported function in adult ataxias. brain 78. velazquez - perez l, seifried c, santos - falcon n, abele m, ziecommun. 2023 ; 5 : fcad064. https : / / doi. org / 1 0. 1 0 9 3 / b r a i n c o m m s / f mann u, almaguer le, et al. saccade velocity is controlled by c a d 0 6 4. polyglutamine size in spinocerebellar ataxia 2. ann neurol. 63. manohar r, yang fx, stephen cd, schmahmann jd, eklund 2004 ; 56 : 444 – 7. nm, gupta as. at - home wearables and machine learning cap - 79. velazquez - perez l, seifried c, abele m, wirjatijasa f, rodriture motor impairment and progression in adult ataxias. medrvix. guez - labrada r, santos - falcon n, et al. saccade velocity is 2024. reduced in presymptomatic spinocerebellar ataxia type 2. clin neurophysiol. 2009 ; 120 : 632 – 5. 1 3 the cerebellum ( 2025 ) 24 : 104 page 11 of 11 104 80. rodriguez - labrada r, velazquez - perez l, auburger g, ziemann 82. lovett a, chary s, babu s, bruneteau g, glass jd, karlsborg m, u, canales - ochoa n, medrano - montero j, et al. spinocerebellar et al. serious neurologic adverse events in tofersen clinical trials ataxia type 2 : measures of saccade changes improve power for for amyotrophic lateral sclerosis. muscle nerve. 2025. https : / / doi clinicaltrials. movdisord. 2016 ; 31 : 570 – 8. https : / / doi. org / 1 0. 1 0. o r g / 1 0.